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Plasmonic/Magnetic 
Multifunctional nanoplatform for 
Cancer Theranostics
M. Ravichandran1, Goldie Oza2, S. Velumani3, Jose Tapia Ramirez2, Francisco Garcia-Sierra4, 
Norma Barragan Andrade4, A. Vera5, L. Leija5 & Marco A. Garza-Navarro6
A multifunctional magneto-plasmonic CoFe2O4@Au core-shell nanoparticle was developed by iterative-
seeding based method. This nanocargo consists of a cobalt ferrite kernel as a core (Nk) and multiple 
layers of gold as a functionalizable active stratum, (named as Nk@A after fifth iteration). Nk@A helps 
in augmenting the physiological stability and enhancing surface plasmon resonance (SPR) property. The 
targeted delivery of Doxorubicin using Nk@A as a nanopayload is demonstrated in this report. The drug 
release profile followed first order rate kinetics optimally at pH 5.4, which is considered as an endosomal 
pH of cells. The cellular MR imaging showed that Nk@A is an efficient T2 contrast agent for both L6  
(r2-118.08 mM−1s−1) and Hep2 (r2-217.24 mM−1s−1) cells. Microwave based magnetic hyperthermia 
studies exhibited an augmentation in the temperature due to the transformation of radiation energy 
into heat at 2.45 GHz. There was an enhancement in cancer cell cytotoxicity when hyperthermia 
combined with chemotherapy. Hence, this single nanoplatform can deliver 3-pronged theranostic 
applications viz., targeted drug-delivery, T2 MR imaging and hyperthermia.
Cancer is the second leading disease which causes major mortality and morbidity worldwide1. In cancer therapy, it is 
crucial to increase the drug specificity and drug efficacy to minimise or completely eradicate significant side-effects on 
patients2. Cancer nanotherapeutics overcome many serious drawbacks of chemotherapy such as non-specific targeting, 
lower efficacy, insolubility of drug moieties in water and oral bioavailability3. Accordingly, Superparamagnetic Iron 
Oxide Nanoparticles (SPIONs) are exploited as an important nanomaterial for cancer detection as well as therapeutics4. 
Such magnetic nanoparticles (NPs) gained its momentum because of their single-domain ordering along with their 
large surface to volume ratio (providing large surface area for attachment of biological entities). Hence, this property 
makes them a suitable candidate as a contrast agent, drug-carrying cargo and hyperthermal agent5. The doping of 
SPIONs with cobalt ions further enhances their magnetic property, thus forming CoFe2O4 nanokernels (Nks). These 
spinel ferrite Nks possess ca. 20–30 times higher magneto-crystalline anisotropy as compared to SPIONs; this increases 
the performance of materials for biomedical applications6–8. Specifically, these Nks are mostly used in biomedicine than 
any other spinel structure because of their enhanced magnetic property and large anisotropy9. The increased superpar-
amagnetism makes them an efficient system for theranostics10–12.
Such superparamagnetic Nks are reactive and toxic to cells; hence, gold NPs are used for creating a shell on 
the magnetic core. This architecture is biocompatible and chemically inert in the physiological system13. The 
core-shell nanoparticles (CSNPs) possesses unique optical and magnetic properties, thus creating an efficient 
platform for nanomedicine14. The significant benefit of the gold nanoshell is to provide complete protection to the 
inner magnetic core from a plethora of environmental factors15. This coat also acts as an excellent platform for 
surface modifications16,17, real-time imaging and drug carrying cargos18,19.
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The major hurdle in synthesising CSNPs is that there is no uniform coating of gold shell on the surface of the 
iron oxide core, even though the ratio between iron and gold is 1:720,21. Therefore, gold iteration is a method that 
improves the formation of CSNPs and controls precisely the thickness of Au shell22,23 on the magnetic core. Even 
though iron oxide and gold CSNPs have been explored extensively24,25 for more than two decades, there are very 
few reports about CoFe2O4@Au nanoparticles21,26.
Doxorubicin (Dox) is one of the potential and most widely used anti-cancer agents for various types of can-
cers. This drug has shown inimical side effects on healthy cells such as cardiotoxicity, mucositis and myelosup-
pression27–29. These adverse effects are minimised by targeted drug delivery which uses specific molecules such as 
folic acid (FA) since cancerous cells overexpress folate receptors on their surface30. Apart from synaphic delivery 
of drugs, the most crucial parameter is its actual release for killing the cancerous cells. The effective release is 
dependent on different types of stimuli such as internal (alterations in pH, temperature, redox condition as well 
as the enzyme activities) or external (such as a magnetic field, radiations and ultrasound)31.
Hyperthermia induced by external magnetic field is the most celebrated mechanism that enhances drug release 
efficiency of the system and are easiest to be used32. The synergistic action of hyperthermia and chemotherapy 
induces apoptosis as well as necrosis in the cancer cells followed by an enhanced immune response. There is a huge 
impact of hyperthermia-combined chemotherapy on the immune system of hosts since they induce both adaptive as 
well as innate immunity. Hence, thermo-chemosenitization is considered as the future of clinical research33.
This work reports multiple iterative gold seed coated cobalt iron oxide nanokernels (Nk@A) as a tri-pronged 
cancer theranostic agent (Fig. 1). The attachment of FA on the surface of Nk@A was used for tethering folate 
receptors present on cancerous cells30. Furthermore, Dox moieties orchestrated on FA attached Nk@A were 
responsible for their anti-cancer activity. Hence, these nanocargos act as proficient drug delivery missiles that 
targets cancer cells. The drug release profiles were studied using release kinetic models. Moreover, these Nk@A 
also served as a T2 contrast agent for MR imaging. Finally, such a complex nanocargo was exploited for microwave 
based localized hyperthermia of cancer cells.
Results and Discussions
Characterization of Plasmonic/Magnetic NPs. XRD analysis was carried out to detect the purity and 
phase crystallinity of the synthesized Nk and Nk@A (Fig. 2). XRD pattern of Nk cubic spinel phase exhibited 
well-defined diffraction peaks that match with the CoFe2O4 structures (JCPDS card no. 22-1086)34. XRD pattern 
of Nk@A showed reflections that corelated well with the FCC ordering of Au (JCPDS card no. 04-0784), thus 
confirming the formation of a nanoshell onto Nk. In this case, only Au diffraction peaks were observed due to 
the heavy metal atom effect of Au18,32. The average particle sizes (Dxrd) of Nk and Nk@A were calculated by con-
sidering the most intense peaks [Nk (220), (311), (440) and Nk@A (111)]. According to Scherrer equation, the 
average crystalline size calculated for Nk was 9.68 nm and for Nk@A, 16.69 nm. The particle sizes obtained were 
well corroborated with corresponding TEM images.
Figure 1. Schematic representation of CoFe2O4 synthesis and Au iterations from 1–5 to enhance the SPR 
property. The surface is modified by attaching activated folic acid for specific targeting of cancer cells and also 
binding with anti-cancer drug doxorubicin for efficient chemotherapy. Finally, the whole complex is employed 
as MRI contrast agent and microwave based hyperthermal cargo at 2.45 GHz to track and treat cancer cells with 
high localization.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:34874 | DOI: 10.1038/srep34874
Figure 3a–d† shows TEM, HR-TEM, HAADF-STEM images and line scan of Nk and Nk@A (1st, 3rd & 5th 
iterations). TEM image of Nks were spherical in shape with the size range of 11–14 nm exhibiting high crystal-
linity with aggregation which is illustrated in Fig. 3a(a*). The crystal lattice structure of Nks were distorted on 
the surface due to the curvature effect. Hence, the gold shell could grow epitaxially on the surface of Nks due to 
a large lattice mismatch. This leads to the formation of Nk as a core and gold as a shell. As iteration increased, 
the size of the core-shell is also increased five times from 1st to 5th iteration with Au nanoshell. This increment 
was due to the continued conjugation of nanogold onto the surface of the core Nk, which lead to the formation 
of Nk@A. HAADF-STEM analysis clearly demonstrated the discrimination between the core and the shell. 
This is because this contrast is directly proportional to atomic number (Z). In the 1st iterative step, the Nk was 
coated with Au nanoshell of around 1–1.5 nm (Fig. 3b(b*)) without any aggregation. This proves that the Au 
iterations not only forms a shell but also stabilizes the nanoparticles. However, in order to enhance the SPR 
property, the iteration was continued; thus leading to the formation of a nanoflower, that constituted of the col-
lective core madeof Nk encapsulated by a thick Au shell. The nanocluster showed jagged-like morphology due 
to non-homogeneously aggregated Nk, which leads to highly asymmetric coating of Au layer (Fig. 3c(c*))35. 
The thick gold nanoshell formation after multiple iterations in the Nk@A solution could be inferred from the 
colour change (Figure S1a in the †ESI). Figure 3c† illustrates the line scan analysis of 3rd iterated nanoflowers 
showing the elemental distribution of Co, Fe and Au in a single nanoparticle. The line scan confirms that Au 
signal is seen on the surface of Nks and Co, Fe signals are enriched in the inner core of the Nks. But as the iter-
ations (5th iterations) continued, the Au seeds started to fill in the empty space of the knobby structures22. This 
resulted in the formation of separated spherical Nk@A and consecutively the shell size increased to 5–6 nm 
(Fig. 3d(d*)). Similar kind of NPs were obtained for Au@Fe3O4, which had a thin shell of Au36. Figure 3d† 
represents the corresponding line scan, which clearly shows the Co K, Fe K edges in the core and Au L edges in 
the shell similar to that of 3rd iterated particles. Additionally to the line scan intensities illustrated in Fig. 3c†,d†, 
it is interesting to define the stoichiometry represented by the Au Lα , whose ratio is higher than the core 
elements such as Co and Fe Kα . This proves that the Au signal is exhibited strongly than the signal from the 
core. Therefore, these results suggest that the formation of CSNPs expressing typical elemental composition of 
high Au content than the core elements, is well corroborated from XRD spectra. The colour mapping shown in 
Fig. 3(a*,b*,c*,d*) proves that the nanostructures are made up of two different metals depending on the elec-
tronic density of the atoms. This colour mapping was carried out using the Digital Micrograph 3.7.0 by Gatan 
software. EDS spectra was carried out to determine the composition of CSNPs for the 1st, 3rd and 5th iterations 
(Figure S1b,c,d in the †ESI) showing the signal of Au, Co & Fe37. The spectra clearly distinguishes the different 
Au iterations from 1 to 5 just by increasing order of Au signal intensity.
The magnetic property of Nk@A is imperative to have an effective penetration in the cancer cell38. SQUID 
analysis (Fig. 4) shows a decrement in magnetic saturation (MS) from 74 to 45 emu/g, along with the diminishing 
hysteretic features. As temperature increased from 5 to 312 K, coercivity (HC) and remanence decreased from 146 
to 32Oe and from 8 to 2 emu/g, respectively (Table S1 in the †ESI).
This magnetic behaviour was attributed to the thermal relaxation of the magnetic moments of the Nk@A. 
This behaviour was also ascribed to the re-orientation of the magnetic moments of NPs caused by the thermal 
energy once it surpassed the magnetic energy imposed by the applied field. Thus, the magnetic characteristics 
of the Nk@A can be ascribed to those expected from a soft ferromagnetic material, even at 312K. This kind of 
ferromagnetic character can be understood from MR imaging which showed high relaxivity values without the 
interference of Au nanoshell. Moreover, in the case of hyperthermia, the Nk@A showed increased heat dissipa-
tion under microwave irradiation in a short span of time.
XPS measurements determined the binding energies and composition of Nk@A. The elements viz., Au, Co, 
Fe, C and O existed within the range from 0 to ≈ 1300 eV. Core level spectra were recorded and represented in 
Figure S3a in the †ESI. Fe2p3/2 and 2p1/2 peaks from Fig. 5a situated at around 711.7 and 725 eV respectively, 
Figure 2. XRD spectrum representing the formation of Nk and Nk@A. 
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were broadened due to the presence of Fe3+ ions in tetrahedral sites39,40. There is also a satellite peak of Fe3+ at 719.6 eV, 
which confirms the presence of Fe3+ 41. The orbitals of Co (Fig. 5b) showed that Co2p3/2 electrons exhibited binding 
energies at 781.2 eV, which corresponds to ions. This may be due to the substitution of Fe3+ ions with Co2+ in the tetra-
hedral site. There is also the existence of a peak at 786.6 eV, which again confirms the presence of Co2+. This is in accord-
ance with the XRD data, which proves that there are no mixed phases of CoO or Fe2O3 in the Nk samples41. Figure 5c 
shows Au binding energies with doublet peaks at 83.8 and 87.4eV thus denoting the Au state of Au4f7/2 and Au4f5/2, 
respectively. This shows that gold ions are completely converted into metallic Au0, leading to the formation of CSNPs. 
Interestingly, the spectrum did not show any detectable Cl2p signal42 which further proved the complete reduction of 
Au onto the surface of Nk (Fig. 5d). The O1s peak showed in Fig. 5e confirmed the presence of oxygen atoms43. The 
C1s signature markers of carbon atom binding energy at 284.7 eV were taken as a reference (Fig. 5f)43. Therefore, XPS 
pattern was in good agreement with XRD data, TEM-EDS and line scanning results.
Tethering folic acid linker and Doxorubicin molecules on Nk@A. UV-Visible absorption spectra of 
different iterations of Nk@A were performed as seen in Fig. 6a. As the number of gold iterations on Nk increased 
from one to three, there was a bathochromic shift of surface plasmon resonance peak (SPR) from 541 to 546 nm. 
In addition, as the iteration increased from three to five, this SPR peak further shifted from 546 to 551 nm. This 
bathochromic shift in the SPR peak was related to the increment in the thickness of gold shells on the surface of 
the magnetic core18. Moreover, as iterations increased, the charge density and the amplitude of the free electron 
oscillation inside the particles also increased. This may be due to the increased surface coating of CTAB, thus 
causing enhanced plasmonic absorption44. The spectra of Nk and Au seeds are also shown in Figure S2 in the 
†ESI. UV-Visible spectra of FA attached Nk@A (Fig. 6b) shows distinct peaks at 280.8 and 375.2 nm, which are 
signature markers of FA. Accordingly, there was a bathochromic shift in the SPR peak after FA attachment which 
showed a peak at 562.4 nm; this shift confirmed that FA formed a complex with Nk@A45. Dox attachment was 
Figure 3. (a(a*)) TEM, HRTEM image of Nk, TEM and HAADF-STEM image of: (b(b*)) 1st iteration 
consisting of very thin Au shell and depicting 2 different contrast which proves the formation of core-shell 
nanoparticles along CTAB layer, (c(c*)) 3rd iteration showing nanoflower formation, (d(d*)) 5th iterative Nk@A 
with thick Au shell around 6–7 nm (Inset representing the colour mapping of corresponding images), (c†,d†) 
Line scan analysis showing the distribution of Fe, Co and Au elements from a single nanoparticle.
Figure 4. Magnetic measurements for Nk@A using SQUID at 5 K, 300 K & 312 K. 
www.nature.com/scientificreports/
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confirmed from the peak (inset) at 490.7 nm with minor red-shift of Nk@A peak (538.9 nm) and slight blue-shift 
of the FA attachment (268.7 & 375.2 nm). These shifts ensured the formation of the Dox-FA-Nk@A complex, 
which is shown in Fig. 6c.
FTIR spectra of functional organic markers on the surface of Nk@A is shown in Fig. 7a. Spectra A represented 
only CTAB peaks (Table S2 in the †ESI)46, which proved that there was an excess amount of CTAB in the solution. 
However, spectra B which was analyzed after repeated centrifugation and washing the Nk@A solution, showed 
a minor peak of CTAB which stabilizes the Au shell (Table S2 in the †ESI). This was also demonstrated from its 
cytocompatibility towards L6 cells, which was evident from MTT assay and confocal microscopy studies.
Figure 7b shows FTIR spectra of FA-Nk@A and Dox-FA-Nk@A. Spectra A represents both activated FA, 
which show bands at 1640.7 cm−1 and 1718 cm−1 expressing –CH stretch and –NH stretch, respectively. FA 
conjugation to Nk@A was confirmed from –NH and –CH stretch; while the asymmetric stretching of primary 
amines –NH and bending vibrations of –CO confirmed the formation of amide linkage between FA and Nk@A 
at 1585.2 cm−1 47. Spectra B represents the attachment of Dox moieties onto FA-Nk@A. The interaction between 
these molecules was via amide linkage, which involved –NH amino group of FA and –COOH carboxylic group 
of Dox. Bands representing these attachments were 1436.8 cm−1 that represents anhydride = CO stretch and 
1651.4 cm−1 denotes amide stretch of = CO. The peak at 2915 cm−1 was a classic peak of secondary –NH2 bend-
ing, and peak at 3000.68 cm−1 corresponded to primary –NH2 bending47.
TGA analysis was carried out for all samples in the temperature range of 30–900 °C under N2 flow atmos-
phere and any change in % weight loss was recorded. TGA graph (Figure S3b in the †ESI) shows Nk, Nk@A, 
FA-Nk@A, Dox-FA-Nk@A, activated FA and Dox. Initially, activated FA and Dox showed a gradual weight loss 
from 30 to 100 °C. The degradation of these moieties was rapid because they are completely organic in nature. 
Nk showed a rapid degradation at 122 °C, which was due to the complete evaporation of water molecules. Then, 
Figure 5. Elemental analysis of Nk@A by XPS which clearly shows the presence of elements such as Fe, Co, 
Au, C, O and absence of Cl. 
Figure 6. (a) UV-Visible absorption spectra showing different iterations from 1–5 with the red shift of Au peak 
representing the increment of nanoshell, UV-Vis spectra of (b) FA functionalization, (c) binding of Dox onto 
FA-Nk@A.
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there was a solid plot up to 555 °C and a drop at 728 °C followed by a slow degradation of bound chlorides and 
hydroxides. In the case of Nk@A, the initial weight loss from 30 to 288 °C was due to the complete desorption of 
water and CTAB molecules from the surface48. The second degradation, from 289 to 595 °C, was a result of the 
covalent interaction of CTA+ ions; the final degradation at a higher temperature, from 596 to 900 °C was most 
likely due to the electrostatic interaction of the ammonium group from CTAB attached to the Au NPs surface49. 
In FA-Nk@A complex, the weight loss in the range of 30–100 °C was due to the desorption of intercrystalline 
water molecules. The second degradation, in the range of 101–750 °C, was due to FA covalent attachment, which 
was seemingly induced by the disintegration of groups like hydroxyl, carboxyl and amino groups present in FA50. 
Dox-FA-Nk@A complex initially showed degradation of water moieties and weak surface interactions of hydro-
gen with the Nk@A. The second decomposition from 96 to 740 °C, was due to the decomposition of FA and Dox 
from the NPs complex and the decomposition from 741 to 900 °C is due to slow degradation of Nk@A51.
Intracellular localization of Dox & Dox-FA-Nk@A. CryoTEM analysis confirmed Nk@A internaliza-
tion and endocytic cavities that contained NPs (Fig. 8a,b) with aggregation, as the pH was acidic. This observation 
gave an insight towards the mechansim of receptor-mediated endocytosis of Nk@A, which can be attributed 
to FA and folate receptor interactions52. Moreover, the cellular uptake of NPs is also dependent on the surface 
charge. Zeta potential (ζ ) values for Nk, Nk@A, FA-Nk@A and Dox-FA-Nk@A complex were in the range of 
+ 11.9 to + 12.1 mV, + 33.4 to + 37.7 mV, − 35.9 to − 38.4 mV, + 16.8 to + 19.4 mV, respectively (Figure S3c in the 
†ESI)53–55. This charge dependency is due to the stability of the complex, which conciliates the harsh physiological 
milieu, such as in the bloodstream or inside the cell. The mechanism of cellular uptake for positively charged nan-
oparticles is interaction of the positive moieties with the negatively charged cell surface56. Rotello and coworkers 
studied the effect of surface charge on the stability of amine functionalized gold nanoparticles. It was found that 
net positive charge caused more displacement of ligands in extracellular57 and intracellular environments58.
Figure 7. FTIR spectra of (a) Nk@A with CTAB before and after washing, (b) The attachment of FA and Dox 
onto Nk@A.
Figure 8. In-vitro cellular uptake of Nk@A (a) CryoTEM image showing the uptake of Nk@A by Hep2 cells, 
(b) magnified view of vesicles showing the cluster of Nk@A entry by the process of endocytosis.
www.nature.com/scientificreports/
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The tracking of Dox-FA-Nk@A inside the cells was performed using confocal microscopy. Hep2 cell lines 
were incubated only with Dox (without any fluorescent dye, since Dox itself is a good bioimaging agent) and it 
showed the internalization. Initially, Dox was distributed all over the cytoplasm (Figure S4a in the †ESI) and cel-
lular membrane, but after 24 h of incubation, the Dox signal in nucleus was very high due to the migration of Dox 
to this compartment and its release promoted by internal pH changes (Figure S4b in the †ESI). This confirmed 
that the binding of Dox molecules to the nuclei by intercalating into DNA leads to inhibition of macromolecular 
biosynthesis59.
In order to assess the cell viability, MTT assay was carried out by incubating L6 and Hep2 cells with Nk, Nk@A, 
FA-Nk@A and Dox-FA-Nk@A for 24 h in the concentration range of 10–50 μ g/mL (Fig. 9a,b). Even though the 
concentrations of all the above complexes increased to 50 μ g/ml, there was not much cytotoxicity observed for L6 
cells. Similarly, Hep2 cells also showed less cytotoxicity when exposed to Nk, Nk@A and FA-Nk@A at concentra-
tions as high as 50 μ g/ml. However, the Hep2 cell viability started decreasing rapidly when the concentration of 
Dox-FA-Nk@A was increased from 10 to 50 μ g/ml. This may be due to the overexpression of folate receptors on the 
surface of Hep2 cells, which increases receptor mediated endocytosis and overall cellular uptake60.
In order to evaluate the cellular and nuclear morphology of L6 and Hep2 cells on incubation with Nk, Nk@A, 
FA-Nk@A and Dox-FA-Nk@A, the cells were examined using confocal microscopy (Figs 10 and 11). The mor-
phology of cells treated with Nk, Nk@A and FA-Nk@A did not show any noticeable change in both L6 and 
Hep2 cells. The activity of Dox-FA-Nk@A, illustrated in Fig. 10(d), showed no effect on L6 cells, while Hep2 
cells [Fig. 11(d)] exhibited major apoptosis caused by disruption of nuclear membrane, which leads to total cell 
damage. This proved that the Dox-FA-Nk@A acted as an efficient nanocargo in delivering the Dox, which finally 
causes cell death. The increased cytotoxicity of Dox-FA-Nk@A can be due to the active transport of Dox by 
receptor-mediated endocytosis mechanism as compared to the passive diffusion of free Dox into the cells61.
In-vitro Dox release kinetics. The in-vitro drug release behavior of Dox-FA-Nk@A was assessed by using 
3 different pH of PBS buffers (5.4, 6.8 & 7.4) for 24 h. We determined that the NPs system was both pH dependent 
and site-specific; which made it as a unique drug delivery system for cancer therapy. As pH decreased in the cellular 
organelles, thereby increasing the release of drugs as seen in Fig. 12a. The cumulative release of Dox at 3 different 
pH after 24 h was 77.9% at pH 5.4, 74.6% at pH 6.8, and 33.6% at pH 7.4, thus confirming pH-dependent release 
mechanism. The pH 7.4 mimics normal physiological pH; hence, drug release is minimum. Moreover, the tumor 
microenvironment exhibits a pH of 6.862,63 where drug release is comparatively more, which occurs due to the partial 
dissociation of the amide bonds between FA and Dox molecules. The complex showed maximum amount of drug 
release at pH 5.4. This pH is a signature marker of endosomal acidic pH consequently leading to the dissociation of 
the drug from the complex by breaking the amide bond between FA and Dox molecules. Moreover, Dox becomes 
highly water-soluble as well as hydrophilic at lower pH as compared to neutral pH. Hence, Dox is in its inactive form 
in normal tissues at neutral pH, while it gains its activity in cancerous tissue at lower pH64.
These results were fitted to different drug kinetic models such as zero order kinetics, first order kinetics, 
Higuchi model and Hixon-Crowell model (Fig. 12b). The drug release followed first order rate kinetics model 
which was attributed to the high regression coefficient value (R2 = 0.9865). This confirms that the drug release is 
pH as well as concentration dependent mechanism.
Magnetic Resonance Imaging in normal and cancerous cells. Nk@A was employed as an efficient 
MR imaging contrast agent. It was cultured with both L6 and Hep2 cells. The cells were harvested and then resus-
pended in PBS with agar gel. These agar phantoms were used to evaluate the T1 and T2-weighted images shown 
in Fig. 13a (only T2-weighted images). As the concentration increased from 0.08–0.64 mM of Nk@A, there was 
an increment in T2-weighed image, which became darker with both cells. The linear relationship was calculated 
in order to obtain the longitudinal relaxivity r1 and transverse relaxivity r2 of both L6 and Hep2 cells incubated 
with Nk@A (Fig. 13b,c). The r1/r2 and r2/r1 values were calculated and are shown in Table S3 in the †ESI. We 
found that the r2/r1value of L6 was 83.15 and for Hep2 it was 120.68. This was much higher than r1/r2 of both, 
Figure 9. MTT assay of (a) L6 cells, (b) Hep2 cells with Nk, Nk@A, FA-Nk@A showing no apoptosis even at 
higher concentrations but Dox-FA-Nk@A treated L6 cells showing very negligible cell death and Hep2 cells 
showing more than 80% cell death at high concentrations.
www.nature.com/scientificreports/
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which confirmed that Nk@A were efficient T2 contrast agent as compared to T1. But in the previous report for 
CoFe2O4@Au, r2/r1value was around 3321. So, we concluded that the increment in the r2/r1 value was mainly due 
to Au iterations.
The r2 value of Nk@A with L6 was 118.08 mM−1s−1 and Hep2 was 217.24 mM−1s−1. This is highly comparable to 
the clinically used MRI contrast agent such as Feridex 105 mM−1s−1 65, which shows noticeable changes after inject-
ing iron oxide NPs66. Therefore this confirmed that the Au nanoshell around Nk did not play a role in Nk core spin67. 
But the r2 value with Hep2 cells showed significant increment when compared to L6 cells because of gold iterations. 
The other reason might be the uptake of gold coated magnetic NPs by cancerous cells was higher than that of normal 
cells68 because the electrostatic interactions of surface charge from gold coating cause more interaction with the 
cell69. Finally, we demonstrated that the Nk@A can be effectively used as an efficient T2 contrast agent.
Microwave based Hyperthermia therapy. Hyperthermia therapy involves increase in the temperature of 
tissues or cells, so that they become more susceptible to anti-cancer drugs. Nk@A nanoparticles were tested as a hyper-
thermal agent under microwave (MW) irradiation by using a microcoaxial double slot antenna as an applicator. The 
increment of temperature as a function of time was measured under ISM (Industrial, Scientific and Medical) approved 
frequency of 2.45 GHz in order to induce localized hyperthermia. The applicator was inserted in the phosphate buff-
ered saline (PBS) containing Nk@A of various concentrations (10–125 μ g/ml) and the increment of temperature was 
measured by using noninterfering fiber optic probes. The MW was irradiated using a home-made setup70 for 150 sec at 
6 W. Interestingly, the temperature increment was very rapid and reached 45 °C in around 75 sec, which was enough to 
kill cancer cells; the temperature raised upto 50–60 °C within 150 sec for Nk@A (Fig. 14a).
The PBS was used as a control which showed maximum rise in temperature as water has the highest absorp-
tion of MW71. This temperature increment was purely based on the Au iterations on Nks. Au nanoshell as well as 
Figure 10. Confocal microscopy study representing the morphology of L6 cells treated with nanoparticles 
for 24 h (a) Nk, (b) Nk@A, (c) FA-Nk@A, (d) Dox-FA-Nk@A which shows no cell death even at higher 
concentration of nanoparticles (Scale bar-20 μ m).
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Figure 11. Confocal microscopy study representing the morphology of Hep2 cells treated with nanoparticles 
for 24 h (a) Nk, (b) Nk@A, (c) FA-Nk@A which shows negligible cell death but (d) Dox-FA-Nk@A clearly 
shows the increased cell death at higher concentration of nanoparticles (Scale bar-20 μ m).
Figure 12. (a) Cumulative release of Dox at 3 different pH, (b) Various plots representing different fitting in 
kinetic models of drug release.
www.nature.com/scientificreports/
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superparamagnetic core led to energy increment which may be due to magnetic anisotropy72 as compared to Nks 
in xylene at 2.45 GHz73. The temperature increment was much higher when compared with Au@γ -Fe2O3, which 
was around 38 °C at 2.45 GHz in water, for 10 mins at a power of 120 W74.
Figure 13. (a) T2 contrast image of Nk@A as the concentration increases the darkening effect also increases 
depending upon the type of cells, (b) r1, (c) r2 relaxivity values of Nk@A incubated with L6 and Hep2 cells.
Figure 14. (a) Plot showing increment of temperature as a function of time with the increased concentrations 
of Nk@A as a potential hyperthermal agent, MTT assay of Hep2 cells (24 h) subjected to hyperthermia (50 °C 
for 50 sec): (b) in-vitro hyperthermia where cells treated with Nk@A which represents the killing of cells as the 
concentration increases by producing enough heat, (c) in-vitro chemohyperthermia where cells treated with 
Dox-FA-Nk@A which represents the killing as the concentration increases by producing heat and also release 
of Dox.
www.nature.com/scientificreports/
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In-vitro Hyperthermia and Chemo-Hyperthermia therapy. Chemo-hyperthermal effect or 
thermo-chemosensitization is quantified by the interaction of anti-cancer drugs with cells at elevated temperature. 
The thermal enhancement ratio (TER) for Dox is 1 at two different temperatures (41.5 °C versus 43.5 °C, respec-
tively)75. There is a relationship between drug-heat interactions on cell cytotoxicity. This pharmacodynamics is 
responsible for enhanced killing of cells. The mechanism of thermal enhancement for drug cytotoxicity includes 
enhanced drug uptake as well as DNA damage and retardation of DNA repair33. There are previous studies, which 
reported the thermal enhancement of cellular cytotoxicity when drug interaction with cells takes place at higher 
temperatures76. In this report, an increase in Nk@A concentration shows an increased cell mortality in addition to 
MW radiation exposure for 50 sec. The cells interacting with increased Nk@A concentration, but without any expo-
sure to MW irradiation (Fig. 14b), showed comparatively lesser mortality than the exposed ones. Both Au shell and 
superparamagnetic core absorb MW, due to which hyperthermia is induced in the cells, thus consequently leading 
to cell death. The viability of Hep2 cells was suppressed more by Dox-FA-Nk@A when exposed to microwave as 
compared to unexposed ones (Fig. 14c). The Dox concentration was considered based on its half-maximal inhibi-
tory concentration (IC50) value of 12.5 μ g. Hence, here the Dox tethered Nk@A concentration was in the range of 
2–14 μ g/ml. The IC50 value of Dox-FA-Nk@A-MW was 8 μ g as compared to the IC50 value of Dox-FA-Nk@A, 
which is 12 μ g. This clearly shows thermal enhancement of Dox cytotoxicity at lower IC50 values in comparison 
with Dox alone. Hence, Dox orchestrated Nk@A efficiently inhibited the cell viability at elevated temperatures 
and very low concentrations of Dox, thus improving the therapeutic proficiency along with minimum side-effects. 
Concurrently, this combined therapy shows efficient synergism, thus exhibiting inimical effect on Hep2 cells.
In summary, we have developed SPR enhanced Nk@A by multiple iterative method, which proved to be 
a promising nanomaterial with multifunctional properties specifically in the field of cancer nanotheranostics. 
These multiple iterations provided a new platform for high surface functionalization. This helped in the efficient 
delivery of drugs, following first order rate kinetics. This Nk@A was also used as a competent MRI contrast 
agent and proved to be an effective T2 agent with high relaxivity values in the presence of both L6 and Hep2 
cells. Finally, Nk@A was used as a hyperthermal agent. In an in-vitro study using Hep2 cells, both Nk@A and 
Dox-FA-Nk@A on exposure to microwave irradiation using 2.45 GHz for 50 sec showed cell mortality. It was 
found that there is an enhancement of cell mortality when MW based hyperthermia collates with Chemotherapy. 
With this efficiency, Nk@A can be used for potential applications as a single nanomaterial for 3 different uses, 
from tracking, diagnosing to therapeutics.
Materials and Methods
Materials. Ferric (III) chloride (FeCl3• 6H2O, 97%), Cobalt (II) nitrate hexahydrate (CoN2O6•6H2O, 
99.999%), sodium hydroxide (NaOH, > 98%), Gold (III) chloride trihydrate (HAuCl4.3H2O, ≥ 99.9%), L-Ascorbic 
acid (AA) (C6H8O6, ≥ 99.0%), Dimethyl sulfoxide (DMSO) (CH3SOCH3, ≥ 99.9%), Sodium chloride (NaCl, ≥ 99.5%), 
Hexadecyltrimethylammonium bromide (CTAB) (CH3(CH2)15N(Br)(CH3)3, ≥ 99.0%), Folic acid (FA) (C19H19N7O6, 
≥ 97%), N-Hydroxysuccinimide (NHS) (C4H5NO3, 98%), N,N′ -Dicyclohexylcarbodiimide (DCC) (C6H11N= 
C= NC6H11, 99%), Triethylamine (TEA) ((C2H5)3N, ≥ 99%), Doxorubicin hydrochloride (Dox) (C27H29NO11• 
HCl), MTT [3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide], Hoechst Stain solution, Phalloidin–
Tetramethylrhodamine B isothiocyanate, and ethanol (CH3CH2OH, ≥ 99.8%) were purchased from Sigma-Aldrich 
(Mexico). Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), and streptomycin were obtained 
from Gibco, Life Technologies. Agarose (UltraPure, Agarose) was purchased from Invitrogen, Thermo scientific. 
Deionized water (DI) was used for all experiments. All chemicals were used directly without any further purification.
Synthesis of Cobalt ferrite (Nk) and gold-coated Nk (Nk@A) NPs. Nk preparation. Magnetic Nk 
were synthesized using co-precipitation method. The precursors 0.5 M of ferric (III) chloride and 0.25 M of cobalt 
(II) nitrate hexahydrate were taken in the ratio of 1:0.5 and in order to avoid the precipitation of the salts, they 
were initially dissolved separately in 10 ml of nitrogen (N2) degassed DI water and mixed with 1.5 M solution of 
40 ml NaOH, which was used as a reducing agent. The entire synthesis process was carried out under N2 atmos-
phere for 1.5 h at 80 °C (pH 12). The black resultant precipitate was separated using a strong magnet and it was 
washed 3 times with DI water. This pure Nk were further used for Nk@A formation.
Nk seed preparation. 200 μ l of synthesized Nk was centrifuged and dispersed in 1 ml of DI water (pH adjusted 
to 7). Then, 400 μ l of DMSO was added and the mixture was stirred continuously under N2 atmosphere at 75 °C 
for 3 h to reduce the aggregation of NPs.
Preparation of gold seed solution. Au coating was carried out for 5 iterations, 5 aliquots of gold seed solution 
were prepared freshly by mixing 0.5 ml (1 M) of CTAB, 1 ml (50 mM) of ascorbic acid, and 100 μ l (1M) of HAuCl4 
solution. This solution complex mixture was sonicated for 15 mins. The golden yellow color immediately changed 
to a milky orange color and then to a milky white color (Figure S1b, (b*) in the †ESI).
Synthesis of Nk@A CSNPs. The seed solution of Nk and gold were used to synthesize Nk@A. In this case, the 
ratio of 1:5 was taken. This was because we had already optimized the ratio with 1:5, 1:7, and 1:9 and found that 
1:5 was appropriate for the Nk@A. Initially, 1 part of milky white colored gold seed solution was added drop-
wise to the faint brown-colored Nk seed solution. This solution mixture was stirred for 2 h continuously until 
the brown colored solution turned into purple. Then, the gold iteration was continued for 5 times for every 2 h. 
Finally, a dark purple color Nk@A solution was obtained. Then, these Nk@A were magnetically separated (after 
each iteration) by magnetic separation technique and they were washed twice with a mixture of hexane and etha-
nol to obtain high purity NPs excluding excess gold NPs. The washed NPs were centrifuged again twice to remove 
excess CTAB from the solution.
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FA Activation and attachment to Nk@A. Activated FA was used for the attachment onto the surface of Nk@A. 
The reason behind the activation of FA was to activate the carboxylate group. This was carried out by dissolving 
FA (0.25 g) into 20 ml of DMSO which was subjected for 1 h sonication to ensure complete dispersion. Later, 
carboxylate group present in FA was activated by mixing 0.125 gm of DCC and 0.225 gm of NHS. The complete 
reaction was carried out under N2 atmosphere at 30 °C for 12 h (FA/DCC/NHS molar ratio 2:1:2). The resultant 
product was filtered using Whatman filter paper; then it was further used for attach onto Nk@A.
Activated FA was used to attach onto the Nk@A. This attachment was carried out by mixing 1ml of activated 
FA and 10 ml of Nk@A under N2 atmosphere and stirring the mixture continuously for 5 h. Then, N2 atmosphere 
was detached and the reaction was continuously stirred for 24 h. Finally, this reaction mixture was filtered using 
Whatman filter paper. Then the process of dialysis was carried out to eliminate unreacted FA using a 3000 kDa 
dialysis membrane in PBS (pH 7.4). After centrifugation, the pellet was again dialyzed in DI water for a period of 
24 h. The activated FA binding onto the surface of Nk@A was studied using UV-Vis spectroscopy analysis.
Synthesis of Dox-FA-Nk@A CSNPs complex. Anthracycline antibiotic Dox was used to kill cancerous cells using 
FA-Nk@A. Activated FA functionalization on Nk@A acted as an anchor for the binding of Dox. To bind Dox, 
5 ml FA-Nk@A was mixed with 1ml of TEA and ml of DMSO as a solvent; finally, 400μ l of 2.36 mM Dox solution 
were added. This mixture was purged using N2 gas under continuous stirring at 60 °C for 5 h. The final complex 
solution was dialyzed to remove the unbound or excess of Dox. The Dox binding was studied by characterization 
techniques, like FTIR and UV-Vis spectroscopy.
Dox loading efficiency and in-vitro Dox release. Before initiating the drug release studies, it was very significant 
to determine the Dox loading efficiency because the exact amount of Dox bound onto FA-Nk@A complex was so 
decisive to calculate the proper drug delivery study (in the †ESI). Dox release studies were carried out by dialysis 
process. Drug release study was determined at 3 different PBS at 37 °C in an incubator of pH 5.3, 6.8 and 7.4 with 
continuous stirring to simulate the intercellular, intracellular and external environment of cancer cells. To carry 
out this study, 2 ml of dialyzed Dox-FA-Nk@A complex was used. Then, 1ml of sample was withdrawn from the 
system every 40mins to determine the drug content. To compensate the PBS solution as soon as 1ml was drawn, 
it was replaced with the same equivalent volume. The amount of Dox released was determined using UV-Vis 
spectrophotometer at 485nm which was the signature absorbance of Dox. All the experiments were repeated 
thrice for all the samples. This drug release study was also explained with different drug kinetics models in order 
to explain the release mechanism.
Characterization. UV-Vis spectroscopy. UV-Vis spectra was obtained using Shimadzu Corporation 
UV-2401PC UV-Vis spectrometer.
X-Ray diffraction (XRD) measurement. The crystallinity of the Nk and Nk@A were recorded by using 
X’Pert PRO XRD spectrometer (PANalytical B.V., Holland) from 10 to 80° (2θ value) using Cu K-α radiation 
(0.15418 nm).
Fourier transform infrared (FT-IR) spectroscopy. FT-IR spectra were obtained on a Nicolet iS50 FT-IR 
Spectrometer (Thermo Scientific).
Thermogravimetric analysis (TGA). Thermal analysis was carried out for liquid samples using a TGA Q50 (TA 
Instruments) from 30 to 900 °C under nitrogen flow with a heating rate of 10 °C/min.
High Resolution Transmission electron microscopy (HRTEM). TEM images were taken on a HRTEM (JEOL, 
JEM-ARM200F) equipped with HAADF-STEM (high-angle annular dark-field scanning transmission electron 
microscopy) detector and Oxford XMax 80 Energy Dispersive X-Ray Spectrometer (EDS). The sample was pre-
pared in such a way that aggregation in the grid was avoided. Then, 10 μ l of sample were dispersed in 100 μ l of 
isopropanol, which was sonicated for 30 mins; then a drop of sonicated nanoparticle dispersion was placed onto 
the amorphous carbon-coated 200 mesh copper grid (Ted Pella, Inc.). Finally, the sample was allowed to dry at 
ambient temperature before it was loaded into the microscope.
CryoTEM. The internalization of NPs inside the cells was confirmed by cryoTEM analysis. 5 μ l of Nk@A nano-
particle suspensions were made into a thin liquid film which was prepared on lacy carbon grid (Pelco, USA) and 
then quenched into liquid ethane to freeze the sample using a Leica EM-CPC chamber. Tecnai F20 (FEI) operated 
at 200 kV to obtain the images which were recorded with a USC1000 slow scan CCD camera (Gatan) at 50000x.
X-Ray photoelectron spectroscopy (XPS) Analysis. XPS analysis were performed using a K-Alpha X 
ray Photoelectron Spectrometer (XPS) System (Surface Analysis, Thermo Scientific). Monochromated, 
Micro-focused Al Kα was used as an X-ray source type. The binding energy of C1s carbon at 284.7 eV was used 
for calibration.
Magnetic measurements. Nk and Nk@A magnetic properties were measured using a superconducting quan-
tum interference device (SQUID), (Quantum Design, MPMS3). The magnetization hysteresis of the samples 
was obtained by changing H between + 70 to − 70 kOe at 3 different temperatures, like 5 K, 300 K and 312 K. The 
hysteresis of the samples was also obtained at 100 kOe using a temperature interval from 1.8 to 312 K.
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Zeta potential measurements. The zeta potential values were determined by using a Zetasizer Nano ZS90 
(Malvern instruments) at 25 °C at a wavelength of He-Ne laser 633 nm, Max 4 mW at a scattering angle of 90° 
using a Universal ‘dip’ cell kit. Data were obtained using a monomodal acquisition according to the Smoluchowski 
theory. The measurements were repeated 3 times. Before the analysis the samples were well sonicated for 1 h to 
avoid aggregation.
Magnetic Resonance Imaging (MRI) experiments. MR imaging was performed with a 7T clinical Signa HDxt 
scanner (Varian). T2-weighted images were acquired using the following parameters: 7T, Repetition time 
TR = 2000 ms, fast spin echo, FOV = 3*3 cm, Echo time TE = 15–250 ms, slice thickness = 4 mm and resolution 
256 × 256 points. For T1 measurements, coronal spin-echo sequences with fixed echo time (TE) = 24 ms and 
varying repetition time (TR) (25 ms to 4 s) were used. Nk@A suspensions was taken at varying concentrations.
Microwave (MW) experiment setup. The setup used to apply the MW electromagnetic field to perform the 
experiments consisted of a generator (SML 03, Rhode & Schwarz, Germany) set to a frequency of 2.45 GHz. This 
signal was then amplified using an RF & MW module power amplifier (1164-BBM3Q6AHM, Empower, USA). 
The output power was then monitored through the use of a dual direct coupler (DC7154M, Amplifier Research, 
USA) and a power meter (PM2002, Amplifier Research, USA) to ensure an output power of 6W and to monitor 
the reflected power of the system. To adjust the standing wave ratio (SWR) to an optimal value, a coaxial stub 
tuner (1878C, Maury Microwave Corp., USA) was used along a network analyzer (E5071B, Agilent Technologies, 
USA) to measure and reduce the SWR to a minimum prior to each experiment.
Temperature Measurements. Non electromagnetic interfering optical fiber probes temperature sensors (M3300, 
Luxtron, USA) were used to record temperature increment. The temperature was measured inside the PBS. 
Each test lasted 200 sec in order to study the temperature response as a function of time. The temperatures were 
recorded every second during the experiments using True Temp software (Luxtron, USA).
Confocal Imaging. Z-series confocal images were collected using Zeiss LSM 700 confocal microscope fitted with 
a 40X oil-immersion lens. Images were processed using Zen 2012 software.
All the above analysis and characterization techniques used liquid sample (FTIR, TGA, UV-Vis spec, HRTEM, 
Zeta potential, Flow cytometry analysis), powder form (SQUID), and thin film (XRD).
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